Beta-Blocker Therapy for Secondary Prevention of Myocardial Infarction in Elderly Diabetic Patients
暂无分享,去创建一个
[1] Philip D. Harvey,et al. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.
[2] S. Gottlieb,et al. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.
[3] H. Krumholz,et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.
[4] H. Krumholz,et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. , 1998, JAMA.
[5] W. Ray,et al. Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas , 1998 .
[6] W. Ray,et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, Archives of internal medicine.
[7] Marciniak Ta. Outcome of acute myocardial infarction according to the specialty of the admitting physician. , 1997 .
[8] L. Rydén,et al. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. , 1997, Cardiovascular research.
[9] J. Chesebro,et al. Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction , 1997, Annals of Internal Medicine.
[10] J. Mccormack,et al. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions , 1997 .
[11] Richard P. Lewis,et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[12] U. Goldbourt,et al. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, The American journal of cardiology.
[13] H. Krumholz,et al. Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.
[14] J. Kjekshus,et al. Beta-blockers and sudden cardiac death. , 1995, Annals of internal medicine.
[15] E. Gilpin,et al. Diabetic patients and beta-blockers after acute myocardial infarction. , 1990, European heart journal.
[16] L. Rydén,et al. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. , 1989, European heart journal.
[17] M. Houston. Adverse effects of antihypertensive drug therapy on glucose intolerance. , 1986, Cardiology clinics.
[18] J. Horn,et al. β-Blockers and Glucose Control , 1985, Drug intelligence & clinical pharmacy.
[19] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[20] J. Kjekshus,et al. Timolol Treatment After Myocardial Infarction in Diabetic Patients , 1983, Diabetes Care.
[21] M. Kendall,et al. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions. , 1983, Pharmacology & therapeutics.
[22] J. Day,et al. Adrenergic mechanisms in control of plasma lipid concentrations. , 1982, British medical journal.
[23] P. Lönnroth,et al. Can insulin-treated diabetics be given beta-adrenergic-blocking drugs? , 1980, British medical journal.
[24] H. Waal-Manning. Can beta-blockers be used in diabetic patients? , 1979, Drugs.
[25] D. Barnett,et al. Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. , 1977, British medical journal.
[26] L. Opie. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. , 1975, The American journal of cardiology.
[27] S. Podolsky,et al. Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy. , 1973, Metabolism: Clinical and Experimental.